| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $61.35M | $60.25M | $50.15M | $45.63M | $43.52M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $322.69M | -$14.39M | -$67.92M | -$229.93M | $15.36M |
| EPS (basic) | 3.3100 | -0.5100 | -1.8600 | -2.0500 | 0.0500 |
| EPS (diluted) | 3.3000 | -0.5100 | -1.8600 | -2.0500 | 0.0500 |
| Shares (diluted) | $94.27M | $52.16M | $43.05M | $117.97M | $80.31M |